CrowdStrike Q1 FY27 — The Print Was Strong; the Multiple Is Stronger

The setup

CrowdStrike walked into its Q1 FY27 print (quarter ended April 30, 2026, reported after the close on June 3) carrying the single hardest expectation in software: a stock up roughly 65% year-to-date, trading near $748 into the close, against a street average target down around $564. That is the textbook "priced for perfection" setup — the bar isn't the published consensus, it's the buy-side whisper that already assumes a beat-and-raise. The story coming in was clean: the July 2024 outage was firmly in the rear-view, retention had healed, and the AI-security narrative had become the reason to own the name rather than a nice-to-have. The risk was never the quarter. It was the price of the quarter.

The numbers

The headline lines beat. Total revenue was $1.386B, +26% YoY (subscription $1.321B, also +26%). Non-GAAP EPS was $1.10 versus $0.73 a year ago and roughly $1.07 consensus. ARR reached $5.51B, +24%, with record Q1 net new ARR of $255.8M, +32% YoY — the metric management most wants you to anchor on. Profitability and cash were the real standouts: non-GAAP operating margin hit 24% (from 18%), record operating cash flow of $590.9M, and record free cash flow of $468.5M — a 34% FCF margin. Non-GAAP subscription gross margin was 81%. GAAP swung to a small profit ($27.8M, $0.11/sh) from a year-ago loss. Management raised the FY27 net new ARR growth guide to ~27.7% at the midpoint (+520 bps), lifted full-year revenue to $5.91–5.96B and non-GAAP EPS to $4.88–4.96, and announced a 4-for-1 stock split (record date June 25, effective July 1, split-adjusted trading July 2).

So why the drop? The tell was billings. Calculated billings landed near $1.35B, up only ~18% YoY — a clear deceleration against 26% revenue and 32% net-new-ARR growth — and total deferred revenue actually declined sequentially (to $4.72B from $4.75B at year-end). For a subscription business, deferred revenue and billings are the leading indicators; ARR and revenue are the trailing ones. A market that has already paid for acceleration will fixate on the one series that decelerated, regardless of how loudly management points at net new ARR. (Billings here is a tkal calculation from the filing — revenue plus the change in total deferred revenue — not a company-reported figure.)